# A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease

> **NCT01322594** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 31 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **BIOLOGICAL:** MEDI2338
- **BIOLOGICAL:** MEDI2338
- **BIOLOGICAL:** MEDI2338
- **BIOLOGICAL:** MEDI2338
- **BIOLOGICAL:** MEDI2338
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01322594
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322594, "A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01322594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*